Let patients be your guide: optimizing trial design with participant input before, during, and after your study

Webinar that looks at making better use of participant insights to generate better evidence

Designing a clinical trial is a challenging multidisciplinary endeavour, and we frequently draw upon the experience of our colleagues in statistics, pharmacology, and clinical medicine to ensure a study is robust. But as a field are we missing the opportunity to engage with those who have the most to offer - namely, those who could potentially participate in our trial? When a trial is failing to hit enrolment targets, or to retain participants in data collection activities we may be quick to go out to participants to gather their feedback and find out how we might improve, but in truth this is probably too late. A well designed trial for a problem that patients don’t consider important is never going to succeed, and conversely a trial of critical importance is not going to succeed if taking part is impossible, particularly for those most disadvantaged by their illness and by structural barriers in society. Increasingly funders, regulators, and sponsors are calling for increased patient involvement before, during, and after a trial is completed, but how does this work in practice? In this webinar you’ll hear perspectives from two experienced practitioners in the field of digital health and decentralized trials across a range of therapeutic areas. You’ll learn about the latest regulatory thinking in the space, gain practical tips for putting patient involvement into practice, and have the opportunity to ask questions and discuss how we can make better use of participant insights to generate better evidence.